11 Participants Needed

PRP for Eyebrow Hypotrichosis and Alopecia Areata

EP
RW
AO
DC
Overseen ByDerm CTU
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of mild to moderate eyebrow hypotrichosis.This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with mild to moderate eyebrow hypotrichosis. Approximately 40 subjects will be randomized to receive platelet-rich plasma (PRP) or saline injections. The study is designed as an 9-month study. This study was a pilot study designed to determine feasibility of this procedure.Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

Research Team

MA

Murad Alam

Principal Investigator

Northwestern University

Eligibility Criteria

This trial is for adults aged 18-85 in the Chicago area with mild to moderate eyebrow thinning who are healthy and can give informed consent. It's not for those with uncontrolled diseases affecting hair growth, recent use of certain hair growth drugs, significant blood disorders, genetic conditions impacting fibroblasts or collagen, pregnant/breastfeeding individuals, or those unable to follow the study protocol.

Inclusion Criteria

Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator
Subjects are in good health as judged by the investigator
You have thin eyebrows, but not too severe.
See 1 more

Exclusion Criteria

You have a medical condition that is not well controlled and could prevent your hair from growing properly.
Patients who have started used agents that may affect eyebrow hair growth (e.g. minoxidil or bimatoprost) within 6 months of screening. Patients who have been using agents that may affect eyebrow hair growth for at least 12 months may be included if the patient agrees to continue their current dosing regimen for the duration of the study
History of a clinically significant hematologic disorder as determined by the investigator
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive intradermal injections of either autologous PRP or sterile saline to eyebrows, with three treatments performed 1 month apart

3 months
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

Treatment Details

Interventions

  • Platelet-rich Plasma
  • Saline
Trial Overview The trial tests if injections of platelet-rich plasma (PRP) help people with sparse eyebrows compared to saline (saltwater) injections. About 40 participants will be randomly chosen to receive either PRP or saline over a period of nine months in this pilot study aimed at assessing procedure feasibility.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Platelet-Rich PlasmaExperimental Treatment1 Intervention
Participants will receive intradermal injections of 2-3mL autologous PRP to eyebrows.Three treatments will be performed 1 month apart.
Group II: Placebo (sterile saline)Placebo Group1 Intervention
Participants will receive intradermal injections of 2-3mL sterile saline to eyebrows.Three treatments will be performed 1 month apart.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security